Please enable JavaScript to continue using this application.

Compare $IKT vs $IPSC | Chartloom

Compare

$IKT vs $IPSC

Inhibikase Therapeutics Inc · Century Therapeutics Inc

IKT

Inhibikase Therapeutics Inc

IPSC

Century Therapeutics Inc

Compare $IKT vs $IPSC

Comparing Inhibikase Therapeutics Inc and Century Therapeutics Inc

IKTInhibikase Therapeutics Inc

IPSCCentury Therapeutics Inc

IKTInhibikase Therapeutics Inc

Market cap

$309M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

1.0%

52W performance

18.7%

FCF yield

-13.8%

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IKT

IPSC

Detailed metrics comparison

IKT

Inhibikase Therapeutics Inc

IPSC

Century Therapeutics Inc

Market Cap

IKT$309M

IPSC$265M

Enterprise Value

IKT$278M

IPSC$215M

Price

IKT$1.97

IPSC$1.47

P/E Ratio

IKTN/A

IPSCN/A

P/S Ratio

IKT872.10x

IPSC2.41x

EV/Sales

IKT774.58x

IPSC1.98x

EV/EBITDA

IKT0.00x

IPSC0.00x

P/B Ratio

IKT1.82x

IPSC1.19x

P/FCF Ratio

IKTN/A

IPSCN/A

EV/FCF

IKT-6.53x

IPSC-2.44x

PEG Ratio

IKTN/A

IPSCN/A

Forward P/E (NTM)

IKTN/A

IPSCN/A

Forward P/S (NTM)

IKTN/A

IPSCN/A

Revenue (TTM)

IKT$0

IPSC$0

Revenue Growth (YoY)

IKTN/A

IPSC-100.0%

Forward Rev Growth

IKT0.0%

IPSC385.7%

Gross Margin (TTM)

IKT0.0%

IPSC0.0%

Operating Margin (TTM)

IKT0.0%

IPSC0.0%

EBITDA Margin (TTM)

IKT0.0%

IPSC0.0%

Net Margin (TTM)

IKT0.0%

IPSC0.0%

FCF Margin (TTM)

IKTN/A

IPSCN/A

Net Income (TTM)

IKT$-44M

IPSC$-110M

FCF (TTM)

IKT$-43M

IPSC$-88M

EPS (TTM)

IKT-$0.25

IPSC-$0.53

ROE (TTM)

IKT-4690.0%

IPSC-5276.0%

ROA (TTM)

IKT-4348.0%

IPSC-4059.0%

ROIC (TTM)

IKT-4690.0%

IPSC-5276.0%

Cash

IKT$31M

IPSC$50M

Debt

IKT$0

IPSC$0

Net Cash/Debt

IKT$31M

IPSC$50M

Current Ratio (TTM)

IKT15.82x

IPSC8.28x

Quick Ratio (TTM)

IKT15.50x

IPSC7.94x

Debt/Equity (TTM)

IKT0.00x

IPSC0.00x

Debt/Assets (TTM)

IKT0.0%

IPSC0.0%

Interest Coverage (TTM)

IKTN/A

IPSCN/A

Net Debt/EBITDA (TTM)

IKT0.00x

IPSC0.00x

Beta

IKT0.92

IPSC1.74

52W Performance

IKT18.7%

IPSC151.9%

YTD Performance

IKT1.0%

IPSC47.8%

% from 52W High

IKT-24.5%

IPSC-51.6%

% from 52W Low

IKT48.1%

IPSC237.9%

Asset Turnover (TTM)

IKT0.01x

IPSC0.31x

FCF Yield (TTM)

IKT-13.8%

IPSC-33.3%

Earnings Yield (TTM)

IKT-14.3%

IPSC-41.4%

Dividend Yield (TTM)

IKTN/A

IPSCN/A

Rule of 40

IKT0.0

IPSC-100.0

EV/GP/RG

IKTN/A

IPSCN/A

Ticker research

View IKT research View IPSC research

Metric	IKT Inhibikase Therapeutics Inc	IPSC Century Therapeutics Inc
Market & Valuation
Market Cap	$309M	$265M
Enterprise Value	$278M	$215M
Price	$1.97	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	872.10x	2.41x
EV/Sales	774.58x	1.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.82x	1.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.53x	-2.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	0.0%	385.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-110M
FCF (TTM)	$-43M	$-88M
EPS (TTM)	-$0.25	-$0.53
ROE (TTM)	-4690.0%	-5276.0%
ROA (TTM)	-4348.0%	-4059.0%
ROIC (TTM)	-4690.0%	-5276.0%
Financial Health
Cash	$31M	$50M
Debt	$0	$0
Net Cash/Debt	$31M	$50M
Current Ratio (TTM)	15.82x	8.28x
Quick Ratio (TTM)	15.50x	7.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.74
52W Performance	18.7%	151.9%
YTD Performance	1.0%	47.8%
% from 52W High	-24.5%	-51.6%
% from 52W Low	48.1%	237.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.31x
FCF Yield (TTM)	-13.8%	-33.3%
Earnings Yield (TTM)	-14.3%	-41.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View IKT research	View IPSC research

Valuation

P/S Ratio

IPSC

2.41x

IKT

872.10x

EV/FCF

IKT

-6.53x

IPSC

-2.44x

Growth & revenue

Revenue Growth TTM

IPSC

-100.0%

Forward Revenue Growth

IPSC

385.7%

IKT

0.0%

Profitability & performance

Gross Margin

IKT

0.0%

IPSC

0.0%

ROE

IKT

-4690.0%

IPSC

-5276.0%

FCF Yield %

IKT

-13.8%

IPSC

-33.3%

52-Week Performance

IPSC

151.9%

IKT

18.7%

Detailed metrics comparison

IKT

Inhibikase Therapeutics Inc

IPSC

Century Therapeutics Inc

Market Cap

IKT$309M

IPSC$265M

Enterprise Value

IKT$278M

IPSC$215M

Price

IKT$1.97

IPSC$1.47

P/E Ratio

IKTN/A

IPSCN/A

P/S Ratio

IKT872.10x

IPSC2.41x

EV/Sales

IKT774.58x

IPSC1.98x

EV/EBITDA

IKT0.00x

IPSC0.00x

P/B Ratio

IKT1.82x

IPSC1.19x

P/FCF Ratio

IKTN/A

IPSCN/A

EV/FCF

IKT-6.53x

IPSC-2.44x

PEG Ratio

IKTN/A

IPSCN/A

Forward P/E (NTM)

IKTN/A

IPSCN/A

Forward P/S (NTM)

IKTN/A

IPSCN/A

Revenue (TTM)

IKT$0

IPSC$0

Revenue Growth (YoY)

IKTN/A

IPSC-100.0%

Forward Rev Growth

IKT0.0%

IPSC385.7%

Gross Margin (TTM)

IKT0.0%

IPSC0.0%

Operating Margin (TTM)

IKT0.0%

IPSC0.0%

EBITDA Margin (TTM)

IKT0.0%

IPSC0.0%

Net Margin (TTM)

IKT0.0%

IPSC0.0%

FCF Margin (TTM)

IKTN/A

IPSCN/A

Net Income (TTM)

IKT$-44M

IPSC$-110M

FCF (TTM)

IKT$-43M

IPSC$-88M

EPS (TTM)

IKT-$0.25

IPSC-$0.53

ROE (TTM)

IKT-4690.0%

IPSC-5276.0%

ROA (TTM)

IKT-4348.0%

IPSC-4059.0%

ROIC (TTM)

IKT-4690.0%

IPSC-5276.0%

Cash

IKT$31M

IPSC$50M

Debt

IKT$0

IPSC$0

Net Cash/Debt

IKT$31M

IPSC$50M

Current Ratio (TTM)

IKT15.82x

IPSC8.28x

Quick Ratio (TTM)

IKT15.50x

IPSC7.94x

Debt/Equity (TTM)

IKT0.00x

IPSC0.00x

Debt/Assets (TTM)

IKT0.0%

IPSC0.0%

Interest Coverage (TTM)

IKTN/A

IPSCN/A

Net Debt/EBITDA (TTM)

IKT0.00x

IPSC0.00x

Beta

IKT0.92

IPSC1.74

52W Performance

IKT18.7%

IPSC151.9%

YTD Performance

IKT1.0%

IPSC47.8%

% from 52W High

IKT-24.5%

IPSC-51.6%

% from 52W Low

IKT48.1%

IPSC237.9%

Asset Turnover (TTM)

IKT0.01x

IPSC0.31x

FCF Yield (TTM)

IKT-13.8%

IPSC-33.3%

Earnings Yield (TTM)

IKT-14.3%

IPSC-41.4%

Dividend Yield (TTM)

IKTN/A

IPSCN/A

Rule of 40

IKT0.0

IPSC-100.0

EV/GP/RG

IKTN/A

IPSCN/A

Ticker research

View IKT research View IPSC research

Metric	IKT Inhibikase Therapeutics Inc	IPSC Century Therapeutics Inc
Market & Valuation
Market Cap	$309M	$265M
Enterprise Value	$278M	$215M
Price	$1.97	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	872.10x	2.41x
EV/Sales	774.58x	1.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.82x	1.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.53x	-2.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	0.0%	385.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-110M
FCF (TTM)	$-43M	$-88M
EPS (TTM)	-$0.25	-$0.53
ROE (TTM)	-4690.0%	-5276.0%
ROA (TTM)	-4348.0%	-4059.0%
ROIC (TTM)	-4690.0%	-5276.0%
Financial Health
Cash	$31M	$50M
Debt	$0	$0
Net Cash/Debt	$31M	$50M
Current Ratio (TTM)	15.82x	8.28x
Quick Ratio (TTM)	15.50x	7.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.74
52W Performance	18.7%	151.9%
YTD Performance	1.0%	47.8%
% from 52W High	-24.5%	-51.6%
% from 52W Low	48.1%	237.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.31x
FCF Yield (TTM)	-13.8%	-33.3%
Earnings Yield (TTM)	-14.3%	-41.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View IKT research	View IPSC research